‘Tumors just vanished’: Cancer patients now in remission after drug trial

Treatment with the immunotherapy dostarlimab showed promising results in a small trial of more than a dozen rectal cancer patients, according to new research, but further study is needed and it is too early to call it a cure. CNN’s Erin Burnett speaks to Dr. Andrea Cercek, an oncologist at Memorial Sloan Kettering Cancer Center. What did you think? Please leave a comment in the section below and remember to share the video and sign up for our free newsletter!